Preparing for an Aging Population: John Hancock and MIT AgeLab Insights
Discover insights on aging preparedness from John Hancock and MIT AgeLab. Learn about health, financial readiness, and the impact of longevity on the insurance industry.
AMA Introduces New Maternity Care Coding for Better Patient Outcomes
Discover how the AMA's new obstetric coding will improve maternity care and patient outcomes starting in 2027. Learn about changes and implications for care providers.
Proposed Senate Bill to Reduce Drug Expenses for Medicare Beneficiaries
A new Senate bill aims to lower prescription drug costs for Medicare beneficiaries by prioritizing affordable generics and biosimilars, providing potential savings.
Medicare Advantage Study on Non-Medical Benefits and Health Outcomes
Explore the $3M Medicare Advantage study examining non-medical benefits like food aid and transportation, assessing their effects on health outcomes and emergency visits.
ACA’s Role in Healthcare Consolidation Debated Amid Policy Review
Discussion on the Affordable Care Act's impact on healthcare consolidation and insurance market trends amidst ongoing subsidy debates and market dynamics.
Congressional Hearing Explores Healthcare Costs, Technology, and Regulation
Congressional hearing investigates rising U.S. healthcare costs, examining regulatory roles and the impact of medical technology innovations on affordability.
Health Care Consolidation Predates the Affordable Care Act, Analysis Finds
Analysis finds health care consolidation and rising costs in the U.S. health system largely predate the Affordable Care Act, with complex market and financial factors driving trends beyond ACA influence.
Challenges and Contradictions in U.S. Health Insurance, FDA Oversight, and Public Health
An overview of key issues in U.S. health insurance, FDA regulatory inconsistencies, health care costs, anti-vaccine impacts, and emerging digital health policies affecting public health.
Expiration of Enhanced ACA Subsidies Threatens Coverage and Strains State Budgets
The expiration of enhanced ACA health insurance subsidies could double premiums, reduce coverage for millions, and strain state budgets, with significant economic and healthcare impacts nationwide.
Medicare Changes to Orphan Drug Price Negotiation Increase Costs
Recent legislative changes to Medicare’s drug price negotiation program expand orphan drug exclusions, delaying price negotiation for expensive specialty drugs and increasing costs for Medicare beneficiaries.